Alpha Centric Advisors LLC United Therapeutics Corp Transaction History
Alpha Centric Advisors LLC
- $118 Million
- Q3 2024
A detailed history of Alpha Centric Advisors LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Alpha Centric Advisors LLC holds 6,250 shares of UTHR stock, worth $2.21 Million. This represents 1.89% of its overall portfolio holdings.
Number of Shares
6,250
Previous 14,500
56.9%
Holding current value
$2.21 Million
Previous $4.62 Million
51.52%
% of portfolio
1.89%
Previous 3.81%
Shares
10 transactions
Others Institutions Holding UTHR
# of Institutions
633Shares Held
45MCall Options Held
368KPut Options Held
410K-
Black Rock Inc. New York, NY5.47MShares$1.93 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.42MShares$1.56 Billion0.03% of portfolio
-
Wellington Management Group LLP Boston, MA3.29MShares$1.16 Billion0.19% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.86MShares$1.01 Billion12.43% of portfolio
-
State Street Corp Boston, MA2.29MShares$809 Million0.03% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $16.1B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...